Bernstein reiterates IBM stock rating amid mainframe weakness
Bernstein reiterates IBM stock rating amid mainframe weakness Investing.com
Covered in this story
What has happened since
- IBM is up 12.8% since this was published, 121 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on IBM
- Stifel: at $252 · target $260 by Oct 2027 · Buy via Investing.com Nigeria
- BMO Capital Markets: at $252 · target $265 by Oct 2027 · Market Perform via Investing.com UK
- Truist Securities: at $252 · target $260 by Oct 2027 via Investing.com UK
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $IBM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on IBM →Dalsna Finance is currently tracking 50 stories mentioning IBM, the earliest published 23 Apr 2026.
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.